Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.
The immunogenicity of different preparations of an oral inactivated enterotoxigenic Escherichia coli (ETEC) vaccine was evaluated in Swedish volunteers previously unexposed to ETEC infection. The vaccine preparations consisted of recombinant cholera toxin B subunit (CTB) and various amounts of formalin-killed whole bacteria expressing the most prevalent colonization factor antigens (CFAs). Significant immunoglobulin A (IgA) antibody-secreting cell (ASC) responses against CTB and the various CFA components were seen in a majority of volunteers after two doses of ETEC vaccine independent of the vaccine lot given. The IgA ASC responses against CTB were significantly higher after the second than after the first immunization, whereas the CFA-specific IgA ASC responses were almost comparable after the first and second doses of ETEC vaccine. Two immunizations with one-third of a full dose of CFA-ETEC bacteria induced lower frequencies of IgA ASC responses against all the different CFAs than two full vaccine doses, i.e., 63 versus 80% for CFA/I, 56 versus 70% for CS1, 31 versus 65% for CS2, and 56 versus 75% for CS4. The proportion of vaccinees responding with rises in the titer of serum IgA antibody against the various CFA antigens was also lower after immunization with the reduced dose of CFA-ETEC bacteria. These findings suggest that measurements of circulating IgA ASCs can be used not only for qualitative but also for quantitative assessments of the immunogenicity of individual fimbrial antigens in various preparations of ETEC vaccine.
Jertborn
M
M
Department of Medical Microbiology and Immunology, Göteborg University, Guldhegsgatan 10, 413 46 Göteborg, Sweden. marianne.jertborn@microbio.gu.se
Ahrén
C
C
Svennerholm
A M
AM
D000284:Administration, Oral; D000328:Adult; D000942:Antigens, Bacterial / Q000276:immunology; D001426:Bacterial Proteins / Q000276:immunology; D002772:Cholera Toxin / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D004927:Escherichia coli Infections / Q000276:immunology* / Q000517:prevention & control*; D022361:Escherichia coli Vaccines / Q000008:administration & dosage / Q000276:immunology*; D005260:Female; D036781:Fimbriae Proteins; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D008297:Male; D013548:Sweden; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000276:immunology
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D022361:Escherichia coli Vaccines; D007070:Immunoglobulin A; D015164:Vaccines, Inactivated; C022924:colonization factor antigens; D036781:Fimbriae Proteins; D002772:Cholera Toxin